A detailed history of Freestone Grove Partners LP transactions in Aptargroup, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 1,318 shares of ATR stock, worth $170,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,318
Previous 4,546 71.01%
Holding current value
$170,232
Previous $675 Million 69.43%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$133.66 - $158.53 $431,454 - $511,734
-3,228 Reduced 71.01%
1,318 $206 Million
Q1 2025

May 15, 2025

SELL
$141.7 - $159.83 $12,327 - $13,905
-87 Reduced 1.88%
4,546 $675 Million
Q4 2024

Feb 14, 2025

BUY
$156.73 - $176.15 $726,130 - $816,102
4,633 New
4,633 $728 Million

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $8.44B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track This Portfolio

Track Freestone Grove Partners LP Portfolio

Follow Freestone Grove Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Grove Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Grove Partners LP with notifications on news.